# Philip Kuriakose

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/philip-kuriakose/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,377 |
| Field | Hemophilia Treatment and Research |
| h-index | 18 |
| i10-index | 32 |
| Last Known Institution | Henry Ford Health System |
| OpenAlex ID | https://openalex.org/A5010706893 |
| ORCID iD | 0000-0001-8054-3459 |
| Works | 176 |

## Researcher papers

- [High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia](https://scholariq.org/papers/high-dose-vincristine-sulfate-liposome-injection-for-advanced-relapsed-and/)
- [Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes](https://scholariq.org/papers/phase-2-randomized-double-blind-study-of-pracinostat-in-combination-with/)
- [Risk of Deep Venous Thrombosis Associated with Chest versus Arm Central Venous Subcutaneous Port Catheters: A 5-Year Single-Institution Retrospective Study](https://scholariq.org/papers/risk-of-deep-venous-thrombosis-associated-with-chest-versus-arm-central-venous/)
- [A cross-sectional analysis of cardiovascular disease in the hemophilia population](https://scholariq.org/papers/a-cross-sectional-analysis-of-cardiovascular-disease-in-the-hemophilia/)
- [Pharmacokinetics and safety of OBI‐1, a recombinant B domain‐deleted porcine factor VIII, in subjects with haemophilia A](https://scholariq.org/papers/pharmacokinetics-and-safety-of-obi-1-a-recombinant-b-domain-deleted-porcine/)
- [Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity](https://scholariq.org/papers/changes-in-the-amino-acid-sequence-of-the-recombinant-human-factor-viia-analog/)
- [A Pilot Study of Thalidomide in Recurrent GI Bleeding Due to Angiodysplasias](https://scholariq.org/papers/a-pilot-study-of-thalidomide-in-recurrent-gi-bleeding-due-to-angiodysplasias/)
- [Frequency and Predictors of Venous Thromboembolism in Orthotopic Liver Transplant Recipients: A Single-Center Retrospective Review](https://scholariq.org/papers/frequency-and-predictors-of-venous-thromboembolism-in-orthotopic-liver/)
- [Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial](https://scholariq.org/papers/addition-of-elotuzumab-to-lenalidomide-and-dexamethasone-for-patients-with-newly/)
- [A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A](https://scholariq.org/papers/a-genome-wide-association-study-of-resistance-to-hiv-infection-in-highly-exposed/)
- [Infusion Reactions With Alternative Therapies During the National Shortage of Iron Dextran](https://scholariq.org/papers/infusion-reactions-with-alternative-therapies-during-the-national-shortage-of-2/)

## Researcher topics

- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Researcher university

- [Henry Ford Health System](https://scholariq.org/institutions/henry-ford-health-system/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.